Symbols / SRTA Stock $4.92 +3.36% Strata Critical Medical, Inc.

Healthcare • Medical Care Facilities • United States • NCM
SRTA (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Care Facilities
CEO Ms. Melissa M. Tomkiel J.D.
Exch · Country NCM · United States
Market Cap 425.32M
Enterprise Value 370.06M
Income -20.07M
Sales 197.14M
FCF (ttm) -26.98M
Book/sh 4.18
Cash/sh 0.70
Employees 327
Insider 10d —
IPO Nov 05, 2019
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S 2.16
P/B 1.18
P/C —
EV/EBITDA -64.82
EV/Sales 1.88
Quick Ratio 5.11
Current Ratio 6.38
Debt/Eq 1.19
LT Debt/Eq —
EPS (ttm) -0.24
EPS next Y —
EPS Growth —
Revenue Growth 83.50%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-06
Earnings (prior) 2026-03-03
ROA -2.71%
ROE -8.01%
ROIC —
Gross Margin 20.86%
Oper. Margin -5.34%
Profit Margin 20.97%
Shs Outstand 86.45M
Shs Float 62.79M
Insider Own 13.26%
Instit Own 75.03%
Short Float 8.72%
Short Ratio 8.81
Short Interest 5.91M
52W High 6.02
vs 52W High -18.27%
52W Low 2.57
vs 52W Low 91.44%
Beta 2.11
Impl. Vol. 1.56%
Rel Volume 1.04
Avg Volume 771.41K
Volume 802.12K
Target (mean) $8.81
Tgt Median $8.00
Tgt Low $8.00
Tgt High $11.25
# Analysts 4
Recom Strong_buy
Prev Close $4.76
Price $4.92
Change 3.36%
About

Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$8.81
Mean price target
2. Current target
$4.92
Latest analyst target
3. DCF / Fair value
$-5.62
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.92
Low
$8.00
High
$11.25
Mean
$8.81

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-25 init Craig-Hallum — → Buy $8
2026-03-25 init B. Riley Securities — → Buy $8
2025-09-17 main Lake Street Buy → Buy $7
News
RSS: Latest SRTA news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-16 WUNSCH SCOTT M Officer — 18,067 $0.00 $0
2026-02-24 COHEN AMIR Officer — 64,191 $0.00 $0
2026-02-24 WUNSCH SCOTT M Officer — 51,353 $0.00 $0
2026-01-02 TOMKIEL MELISSA M. Chief Executive Officer — 276,960 $0.18 $49,853
2025-12-09 HEYBURN WILLIAM A Chief Executive Officer — 17,000 $4.47 $76,044
2025-12-05 LAUCK ANDREW Director — 5,000 $4.36 $21,825
2025-12-02 WUNSCH SCOTT M Officer — 13,395 $0.00 $0
2025-12-02 COOK WILLIAM L III Director — 53,233 $0.00 $0
2025-12-02 VERDETTO LOUIS R Officer — 63,918 $0.00 $0
2025-11-20 LOVE REGINALD LAMONTE Director — 11,000 $4.37 $48,070
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
197.14
+34.28%
146.82
-34.80%
225.18
+54.11%
146.12
Operating Revenue
197.14
+34.28%
146.82
-34.80%
225.18
+54.11%
146.12
Cost Of Revenue
156.01
+33.09%
117.23
-35.96%
183.06
+47.81%
123.84
Reconciled Cost Of Revenue
150.43
+33.69%
112.52
-38.53%
183.06
+47.81%
123.84
Gross Profit
41.13
+38.99%
29.59
-29.75%
42.12
+89.10%
22.27
Operating Expense
63.48
+21.81%
52.11
-52.73%
110.24
+45.43%
75.80
Research And Development
—
3.18
-31.19%
4.63
-16.56%
5.54
Selling General And Administration
60.88
+19.70%
50.86
-51.85%
105.61
+50.32%
70.26
Selling And Marketing Expense
—
7.95
-23.84%
10.44
+34.70%
7.75
General And Administrative Expense
—
81.71
-14.15%
95.17
+52.25%
62.51
Other Gand A
—
81.71
-14.15%
95.17
+52.25%
62.51
Total Expenses
219.49
+29.62%
169.34
-42.26%
293.30
+46.91%
199.65
Operating Income
-22.35
+0.76%
-22.52
+66.93%
-68.12
-27.25%
-53.53
Total Operating Income As Reported
-22.35
+0.76%
-22.52
+66.93%
-68.12
-27.25%
-53.53
EBITDA
-14.17
+14.46%
-16.56
+72.85%
-61.01
-27.62%
-47.80
Normalized EBITDA
-12.21
+22.27%
-15.71
+75.11%
-63.14
+9.63%
-69.87
Reconciled Depreciation
8.19
+37.29%
5.96
-16.16%
7.11
+24.21%
5.72
EBIT
-22.35
+0.76%
-22.52
+66.93%
-68.12
-27.25%
-53.53
Total Unusual Items
-1.95
-129.88%
-0.85
-139.85%
2.13
-90.33%
22.06
Total Unusual Items Excluding Goodwill
-1.95
-129.88%
-0.85
-139.85%
2.13
-90.33%
22.06
Net Income
41.35
+251.42%
-27.31
+51.30%
-56.08
-105.71%
-27.26
Pretax Income
-20.07
-24.16%
-16.16
+71.91%
-57.54
-105.27%
-28.03
Net Non Operating Interest Income Expense
4.24
-41.21%
7.21
-14.55%
8.44
+145.84%
3.43
Net Interest Income
4.24
-41.21%
7.21
-14.55%
8.44
+145.84%
3.43
Interest Income Non Operating
4.24
-41.21%
7.21
-14.55%
8.44
+145.84%
3.43
Interest Income
4.24
-41.21%
7.21
-14.55%
8.44
+145.84%
3.43
Other Income Expense
-1.95
-129.88%
-0.85
-139.85%
2.13
-90.33%
22.06
Gain On Sale Of Security
-1.95
-129.88%
-0.85
-139.85%
2.13
-90.33%
22.06
Tax Provision
0.00
0.00
+100.00%
-1.47
-89.90%
-0.77
Tax Rate For Calcs
0.00
0.00
-100.00%
0.00
-7.27%
0.00
Tax Effect Of Unusual Items
0.00
0.00
-100.00%
0.05
-91.04%
0.61
Net Income Including Noncontrolling Interests
41.35
+251.42%
-27.31
+51.30%
-56.08
-105.71%
-27.26
Net Income From Continuing Operation Net Minority Interest
-20.07
-24.16%
-16.16
+71.18%
-56.08
-105.71%
-27.26
Net Income From Continuing And Discontinued Operation
41.35
+251.42%
-27.31
+51.30%
-56.08
-105.71%
-27.26
Net Income Continuous Operations
-20.07
-24.16%
-16.16
+71.18%
-56.08
-105.71%
-27.26
Net Income Discontinuous Operations
61.41
+650.99%
-11.15
—
—
Normalized Income
-18.11
-18.29%
-15.31
+73.67%
-58.15
-19.37%
-48.72
Net Income Common Stockholders
41.35
+251.42%
-27.31
+51.30%
-56.08
-105.71%
-27.26
Diluted EPS
—
-0.34
+54.76%
-0.76
-99.79%
-0.38
Basic EPS
—
-0.34
+54.76%
-0.76
-99.79%
-0.38
Basic Average Shares
—
79.42
+8.02%
73.52
+2.60%
71.66
Diluted Average Shares
—
79.42
+8.02%
73.52
+2.60%
71.66
Diluted NI Availto Com Stockholders
41.35
+251.42%
-27.31
+51.30%
-56.08
-105.71%
-27.26
Amortization
2.60
+107.00%
1.26
—
—
Amortization Of Intangibles Income Statement
2.60
+107.00%
1.26
—
—
Depreciation Amortization Depletion Income Statement
2.60
+107.00%
1.26
—
—
Depreciation And Amortization In Income Statement
2.60
+107.00%
1.26
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
325.47
+26.80%
256.68
-12.97%
294.94
-9.26%
325.02
Current Assets
126.19
-21.49%
160.74
-22.07%
206.26
-5.44%
218.13
Cash Cash Equivalents And Short Term Investments
61.23
-50.95%
124.83
-24.86%
166.14
-13.51%
192.08
Cash And Cash Equivalents
30.97
+92.68%
16.07
-42.34%
27.87
-32.57%
41.34
Other Short Term Investments
30.26
-72.17%
108.76
-21.34%
138.26
-8.28%
150.74
Receivables
39.96
+101.58%
19.82
-5.63%
21.00
+93.11%
10.88
Accounts Receivable
39.96
+101.58%
19.82
-5.63%
21.00
+93.11%
10.88
Gross Accounts Receivable
41.02
+106.96%
19.82
-6.07%
21.10
+94.01%
10.88
Allowance For Doubtful Accounts Receivable
-1.07
0.00
+100.00%
-0.10
0.00
Prepaid Assets
—
—
—
—
Restricted Cash
0.26
+0.38%
0.26
-77.09%
1.15
-62.79%
3.08
Assets Held For Sale Current
0.00
-100.00%
11.15
—
—
Other Current Assets
24.74
+429.06%
4.68
-73.98%
17.97
+48.69%
12.09
Total Non Current Assets
199.28
+107.73%
95.93
+8.18%
88.68
-17.05%
106.90
Net PPE
39.55
+26.38%
31.30
+18.62%
26.38
+33.73%
19.73
Gross PPE
45.84
+35.33%
33.87
+14.67%
29.54
+34.49%
21.96
Accumulated Depreciation
-6.29
-144.21%
-2.57
+18.42%
-3.15
-41.23%
-2.23
Machinery Furniture Equipment
5.30
+1221.45%
0.40
-54.74%
0.89
+117.69%
0.41
Other Properties
3.17
+10.07%
2.88
-87.94%
23.89
+32.54%
18.02
Leases
0.83
+13.76%
0.73
-75.66%
3.02
+7.75%
2.80
Goodwill And Other Intangible Assets
135.71
+477.40%
23.50
-61.40%
60.89
-29.04%
85.81
Goodwill
88.21
+467.63%
15.54
-61.51%
40.37
+2.35%
39.45
Other Intangible Assets
47.50
+496.46%
7.96
-61.19%
20.52
-55.74%
46.37
Investments And Advances
—
—
—
0.39
Long Term Equity Investment
—
—
—
0.39
Other Non Current Assets
24.02
-41.61%
41.13
+2833.88%
1.40
+3.09%
1.36
Total Liabilities Net Minority Interest
46.40
+33.58%
34.74
-42.71%
60.64
+19.99%
50.54
Current Liabilities
19.79
-12.90%
22.73
-35.97%
35.49
+33.39%
26.61
Payables And Accrued Expenses
19.14
+107.61%
9.22
-61.36%
23.86
+44.29%
16.54
Payables
—
—
—
—
Accounts Payable
—
—
—
—
Current Debt And Capital Lease Obligation
0.65
-4.40%
0.68
-85.75%
4.79
+42.39%
3.36
Current Capital Lease Obligation
0.65
-4.40%
0.68
-85.75%
4.79
+42.39%
3.36
Current Deferred Liabilities
—
6.66
-2.76%
6.84
+2.03%
6.71
Current Deferred Revenue
—
6.66
-2.76%
6.84
+2.03%
6.71
Other Current Liabilities
—
12.82
—
—
Total Non Current Liabilities Net Minority Interest
26.61
+121.51%
12.01
-52.24%
25.15
+5.09%
23.93
Liabilities Heldfor Sale Non Current
0.00
-100.00%
3.87
—
—
Long Term Debt And Capital Lease Obligation
2.65
+13.66%
2.34
-88.16%
19.74
+31.85%
14.97
Long Term Capital Lease Obligation
2.65
+13.66%
2.34
-88.16%
19.74
+31.85%
14.97
Non Current Deferred Liabilities
0.35
0.00
-100.00%
0.45
-75.96%
1.88
Non Current Deferred Taxes Liabilities
0.35
0.00
-100.00%
0.45
-75.96%
1.88
Other Non Current Liabilities
22.07
—
—
—
Stockholders Equity
279.07
+25.74%
221.94
-5.28%
234.30
-14.64%
274.49
Common Stock Equity
279.07
+25.74%
221.94
-5.28%
234.30
-14.64%
274.49
Capital Stock
0.01
+0.00%
0.01
+0.00%
0.01
+0.00%
0.01
Common Stock
0.01
+0.00%
0.01
+0.00%
0.01
+0.00%
0.01
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
86.70
+9.17%
79.42
+5.71%
75.13
+4.84%
71.66
Ordinary Shares Number
86.70
+9.17%
79.42
+5.71%
75.13
+4.84%
71.66
Additional Paid In Capital
424.62
+4.31%
407.08
+4.36%
390.08
+3.78%
375.87
Retained Earnings
-145.55
+22.12%
-186.90
-16.99%
-159.75
-54.09%
-103.68
Gains Losses Not Affecting Retained Earnings
0.00
-100.00%
1.75
-55.78%
3.96
+73.33%
2.29
Other Equity Adjustments
—
1.75
-55.78%
3.96
+73.33%
2.29
Total Equity Gross Minority Interest
279.07
+25.74%
221.94
-5.28%
234.30
-14.64%
274.49
Total Capitalization
279.07
+25.74%
221.94
-5.28%
234.30
-14.64%
274.49
Working Capital
106.40
-22.91%
138.02
-19.18%
170.77
-10.83%
191.52
Invested Capital
279.07
+25.74%
221.94
-5.28%
234.30
-14.64%
274.49
Total Debt
3.31
+9.58%
3.02
-87.69%
24.52
+33.78%
18.33
Capital Lease Obligations
3.31
+9.58%
3.02
-87.69%
24.52
+33.78%
18.33
Net Tangible Assets
143.36
-27.75%
198.43
+14.43%
173.41
-8.09%
188.68
Tangible Book Value
143.36
-27.75%
198.43
+14.43%
173.41
-8.09%
188.68
Current Notes Payable
—
—
—
—
Derivative Product Liabilities
1.53
-73.66%
5.81
+17.14%
4.96
-30.00%
7.08
Investmentsin Joint Venturesat Cost
—
—
—
0.39
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-48.91
-1841.80%
-2.52
+92.21%
-32.35
+12.88%
-37.13
Cash Flow From Continuing Operating Activities
-48.91
-1841.80%
-2.52
+92.21%
-32.35
+12.88%
-37.13
Net Income From Continuing Operations
41.35
+251.42%
-27.31
+51.30%
-56.08
-105.71%
-27.26
Depreciation Amortization Depletion
8.19
+37.29%
5.96
-16.16%
7.11
+24.21%
5.72
Depreciation
—
2.98
+176.84%
1.07
—
Amortization Cash Flow
—
2.99
-50.53%
6.04
—
Depreciation And Amortization
8.19
+37.29%
5.96
-16.16%
7.11
+24.21%
5.72
Amortization Of Intangibles
—
2.99
-50.53%
6.04
—
Other Non Cash Items
-52.43
-1088.26%
-4.41
+31.84%
-6.47
-491.68%
-1.09
Stock Based Compensation
17.83
-10.36%
19.89
+59.13%
12.50
+51.03%
8.28
Asset Impairment Charge
1.67
-70.95%
5.76
-72.47%
20.92
0.00
Deferred Tax
0.43
+269.41%
-0.26
+82.61%
-1.47
-89.90%
-0.77
Deferred Income Tax
0.43
+269.41%
-0.26
+82.61%
-1.47
-89.90%
-0.77
Operating Gains Losses
-56.88
-6791.41%
0.85
+140.00%
-2.12
+90.34%
-21.99
Gain Loss On Investment Securities
0.92
+7.88%
0.85
+140.00%
-2.12
+90.37%
-22.06
Net Foreign Currency Exchange Gain Loss
-0.80
0.00
-100.00%
0.01
+0.00%
0.01
Gain Loss On Sale Of PPE
—
—
0.05
-29.41%
0.07
Change In Working Capital
-9.08
-201.76%
-3.01
+55.34%
-6.74
-39529.41%
-0.02
Change In Receivables
-12.03
-1105.81%
-1.00
+90.27%
-10.25
-91.77%
-5.35
Changes In Account Receivables
-12.03
-1105.81%
-1.00
+90.27%
-10.25
-91.77%
-5.35
Change In Prepaid Assets
-1.69
-126.54%
6.35
+205.31%
-6.03
-14.79%
-5.25
Change In Payables And Accrued Expense
2.38
+128.52%
-8.34
-192.14%
9.05
-8.60%
9.90
Change In Other Working Capital
1.60
+3446.67%
0.04
-90.93%
0.50
-63.20%
1.35
Change In Other Current Assets
0.67
+1051.43%
-0.07
-1850.00%
0.00
+100.60%
-0.66
Investing Cash Flow
69.75
+6965.16%
-1.02
-105.95%
17.09
-78.46%
79.34
Cash Flow From Continuing Investing Activities
69.75
+6965.16%
-1.02
-105.95%
17.09
-78.46%
79.34
Net PPE Purchase And Sale
-9.60
+68.91%
-30.86
-1465.80%
-1.97
-170.00%
-0.73
Purchase Of PPE
-9.60
+68.91%
-30.86
-1363.35%
-2.11
-188.90%
-0.73
Sale Of PPE
—
0.01
-90.58%
0.14
0.00
Capital Expenditure
-11.01
+66.62%
-32.98
-1463.82%
-2.11
-188.90%
-0.73
Capital Expenditure Reported
-1.42
+33.22%
-2.12
0.00
—
Net Investment Purchase And Sale
150.10
+338.97%
34.20
+79.04%
19.10
-85.12%
128.36
Purchase Of Investment
-146.26
-2.10%
-143.25
+46.14%
-265.97
-16.65%
-228.02
Sale Of Investment
296.36
+67.01%
177.45
-37.75%
285.07
-20.01%
356.38
Net Business Purchase And Sale
-69.34
-3009.64%
-2.23
-5617.95%
-0.04
+99.92%
-48.29
Purchase Of Business
-69.34
-3009.64%
-2.23
-5617.95%
-0.04
+99.92%
-48.29
Gain Loss On Sale Of Business
-57.00
0.00
—
—
Net Intangibles Purchase And Sale
—
—
—
0.00
Purchase Of Intangibles
—
—
—
0.00
Financing Cash Flow
-8.91
-54.75%
-5.76
-7477.63%
-0.08
+92.99%
-1.08
Cash Flow From Continuing Financing Activities
-8.91
-54.75%
-5.76
-7477.63%
-0.08
+92.99%
-1.08
Net Issuance Payments Of Debt
—
—
—
0.00
Issuance Of Debt
—
—
—
—
Repayment Of Debt
—
—
—
0.00
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
—
—
—
0.00
Net Long Term Debt Issuance
—
—
—
0.00
Net Common Stock Issuance
0.00
+100.00%
-0.24
0.00
0.00
Common Stock Payments
0.00
+100.00%
-0.24
0.00
—
Repurchase Of Capital Stock
0.00
+100.00%
-0.24
0.00
—
Proceeds From Stock Option Exercised
0.19
+14.88%
0.17
+140.00%
0.07
-19.54%
0.09
Net Other Financing Charges
-9.11
-60.21%
-5.68
-3792.47%
-0.15
+87.53%
-1.17
Changes In Cash
11.92
+228.30%
-9.29
+39.40%
-15.34
-137.29%
41.13
Effect Of Exchange Rate Changes
-0.34
-323.75%
-0.08
-21.21%
-0.07
-191.67%
0.07
Beginning Cash Position
19.65
-32.30%
29.02
-34.67%
44.42
+1277.46%
3.23
End Cash Position
31.23
+58.97%
19.65
-32.30%
29.02
-34.67%
44.42
Free Cash Flow
-59.92
-68.80%
-35.50
-3.02%
-34.46
+8.99%
-37.86
Interest Paid Supplemental Data
—
—
—
0.00
Income Tax Paid Supplemental Data
0.09
0.00
-100.00%
0.02
0.00
Common Stock Issuance
—
—
—
0.00
Issuance Of Capital Stock
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category